moxonidine has been researched along with Edema-Proteinuria-Hypertension Gestosis in 1 studies
moxonidine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Optimal cardiovascular prevention after preeclampsia should be further explored." | 3.11 | Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-controlled cross-over trial (the PALM study). ( Franx, A; Groenhof, TKJ; Paauw, ND; Spiering, W; Titia Lely, A; Veerbeek, JHW; Verhaar, MC; Zoet, GA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zoet, GA | 1 |
| Paauw, ND | 1 |
| Veerbeek, JHW | 1 |
| Groenhof, TKJ | 1 |
| Spiering, W | 1 |
| Verhaar, MC | 1 |
| Franx, A | 1 |
| Titia Lely, A | 1 |
1 trial available for moxonidine and Edema-Proteinuria-Hypertension Gestosis
| Article | Year |
|---|---|
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-controlled cross-over trial (the PALM study).
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Cross-Over | 2022 |